Blueprint Medicines Corporation (BPMC) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Blueprint Medicines Corporation, Ultragenyx Pharmaceutical Inc..Total Return (%)
Blueprint Medicines Corporation (BPMC)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Ultragenyx Pharmaceutical Inc.
RARE
| Metric | Blueprint Medicines Corporation (BPMC) | Ultragenyx Pharmaceutical Inc. (RARE) |
|---|---|---|
| Current Price | $84.69 | $35.69 |
| Change | 2.58 (3.14%) | 0.71 (2.03%) |
| Market Cap | $5.41B | $3.35B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -90.10 | -6.98 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $121.90 | $60.37 |
| 52-Week Low | $73.04 | $29.59 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.07 | $-6.29 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BPMC | -4.54% | -24.36% | -6.53% | 20.80% | 348.81% | 348.81% |
| RARE | -8.91% | -13.54% | -18.31% | -42.55% | -44.43% | -42.98% |